Caution should be exercised especially in the context of IgM paraprotein-related MGRS where the neoplastic clone may be a lymphoplasmacytic lymphoid infiltrate and treatment regimens designed for MM may not be appropriate. The gene discussed is CD40LG; the disease is Miyoshi myopathy.